Merrimack Pharmaceuticals

+$0.03 (+0.48%) Today
$0.00 (0.00%) As of 8:38 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MACK and other ETFs, options, and stocks.

About MACK

Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310.

CEO
Gary L. Crocker
Employees
—
Headquarters
Cambridge, Massachusetts
Founded
1993

MACK Key Statistics

Market Cap
85.57M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
26.73K
High Today
$6.30
Low Today
$6.13
Open Price
$6.15
Volume
32.45K
52 Week High
$9.45
52 Week Low
$3.20

MACK Earnings

-$0.09
-$0.05
-$0.02
$0.02
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 5, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure